AMBOSS

Berlin, Germany Founded: 2012 • Age: 14 yrs
Mobile and cloud-based resources for medical exams are delivered.

About AMBOSS

AMBOSS is a Healthcare company based in Berlin (Germany) founded in 2012 by Madjid Salimi, Ehsan Khaljani, Sievert white, and Sievert Weiss. Mobile and cloud-based resources for medical exams are delivered. It operates in the Healthcare and Education sectors. AMBOSS has raised $291.94 million across 3 funding rounds from investors including M&G, Partech Partners and Lightrock. AMBOSS has completed 1 acquisition, including Novaheal. Its chief executive, as recorded, is Madjid Salimi. Its website amboss.com draws about 7.1 million monthly visits. AMBOSS offers products and services including AMBOSS Platform, Qbank, Knowledge Library, and AMBOSS App. Its focus areas include HealthTech, Healthcare IT, Provider and Administrative Solutions. Its legal entity is AMBOSS GmbH.

Company details

AMBOSS was founded in 2012 in Berlin, Germany, and operates in the medical education sector. Cloud-based and mobile resources, including question banks, review books, textbooks, lecture notes, personal notes, and multimedia, are provided for medical students and physicians. Learning cards are offered specifically for physicians on a subscription basis. The platforms app is available for Android and iOS devices.

  • Headquarters Berlin, Germany
  • Founders Madjid Salimi, Ehsan Khaljani, Sievert white, Sievert Weiss
  • Sectors
    Healthcare
    Education
  • Website category Health · Medicine
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website amboss.com/us
  • Social LinkedIn X Facebook Instagram YouTube
  • Legal Name Amboss Gmbh
Key Metrics
  • Total Equity Funding
    $291.94M (USD)

    in 3 rounds

  • Latest Funding Round
    $259.12M (USD), Series C

    Mar 2025

  • Investors
    M&G

    & 7 more

  • Investments & Acquisitions

Products & Services of AMBOSS

AMBOSS offers a comprehensive portfolio of products and services, including AMBOSS Platform, Qbank, Knowledge Library, and AMBOSS App.

AMBOSS Platform
Education Software

Comprehensive tool for medical exam preparation and clinical reference

Qbank
Question Bank

Case-based questions for medical exam practice and learning

Knowledge Library
Medical Articles

Extensive articles for quick clinical information access

AMBOSS App
Mobile Tool

App for on-the-go medical knowledge and study aids

Apps and channels of AMBOSS

AMBOSS publishes 2 mobile apps with over 500K+ downloads; its YouTube channel AMBOSS: Medical Knowledge Distilled has 332K subscribers and 30 videos.

AMBOSS Knowledge Library
Google Play Medical Everyone Free
Developer: AMBOSS
View on Google Play
AMBOSS Medical Knowledge
App Store Medical 17+
Developer: AMBOSS
View on App Store
AMBOSS: Medical Knowledge Distilled
YouTube 332K subscribers 30 videos Education
Open channel

Videos from AMBOSS

The most watched videos on AMBOSS's YouTube channel, AMBOSS: Medical Knowledge Distilled (332K subscribers). Click a video to play it here.

Gowning and gloving | AMBOSS tutorial
611.5K views
Scrubbing in (surgical scrub): brush-stroke method | AMBOSS tutorial
327.7K views
Gloving (open glove method) | AMBOSS tutorial
227.3K views
Alcohol-based surgical hand disinfection | AMBOSS tutorial
53.9K views

More on AMBOSS: Medical Knowledge Distilled.

Funding Insights of AMBOSS

AMBOSS has successfully raised a total of $291.94M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $259.12 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $291.94M
  • Total Rounds 3
  • Last Round Series C β€” $259.12M
  • Investors Count 8

All 3 funding rounds of AMBOSS with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2025$259.12MSeries C––
Sep 2019$32.81MSeries B–Partech Partners, Target Global
Jun 2017Series A–Cherry Ventures
–
Valuation history

8 investors in total: 8 institutional.

Investors in AMBOSS

AMBOSS has secured backing from 8 investors, including venture fund investors. Prominent investors backing the company include M&G, Partech Partners and Lightrock.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
KIRKBI is engaged in building a better future for children.
kirkbi.comBillund, Denmark
Diversified asset management firm and private fund focused on debt and equity investments in climate startups, real estate, and multiple sectors
1931mandg.comLondon, United Kingdom
Investments are directed toward growth-stage companies generating scalable impact.
2009lightrock.comLondon, United Kingdom
Venture capital is provided to global tech startups and scale-ups.
1982partechpartners.comParis, France
Venture capital firm
targetglobal.vcLondon, United Kingdom
Provider of early-stage venture capital funding for European technology companies
cherry.vcBerlin, Germany
Early-stage tech investments are targeted in US, UK, and Germany.
holtzbrinck-digital.comMunich, Germany
Investments are made in early-stage healthcare startups.
wellington-partners.comMunich, Germany
Premium access

Investor details for AMBOSS

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of AMBOSS

67 people are tracked at AMBOSS (20 in leadership, 47 in team).

NameRoleGroup
Madjid Salimi
Co-Founder & Co-CEOLeadership
Ehsan Khaljani
Co-Founder & Co-CEOLeadership
Sievert white
Co-FounderLeadership
Sievert Weiss
Co-FounderLeadership
Benedikt Hochkirchen
Co-Founder & Co-CEOLeadership
Chad Jennings
VP, Product & DesignLeadership
Nick Turner
Head Of B2b Sales Europe & CanadaLeadership
Sascha Krause
Director Of Product EngineeringLeadership
Heather Stever
Head Of US Campus SalesLeadership
Stefan Mampilly
Head of Global B2B SalesLeadership
Sandra Hoffer von Ankershoffen
Head Of Accounting & TaxLeadership
Bianca Quell
VP Commercial - B2b Sales & MarketingLeadership
Meike Schmidt
Vice President OperationsLeadership
Erika R.
Head Of PeopleLeadership
Niklas Büscher
Editor-in-chief & US Student Product Strategy LeadLeadership
Elke Broßmann
Head Of People OperationsLeadership
George Hadjichristofis
Director FinanceLeadership
Yulia Morozova
Director Of Sales Operations - GlobalLeadership
Bill Stathias
Head Of CRMLeadership
Roman Georgi
Director Of Customer SupportLeadership

47 more people are available in the full profile.

Premium access

Complete people profiles for AMBOSS

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by AMBOSS

AMBOSS has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Novaheal.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Nursing courses are delivered via an online education platform.
novaheal.deBochum, Germany2021Oct 2024β€’β€’β€’β€’
Premium access

Complete acquisition details for AMBOSS

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of AMBOSS

4 dated milestones of AMBOSS across 13 years, from founding to its latest funding, stage changes and deals.

  1. Founded AMBOSS is founded.
  2. Funding First funding round.
  3. Acquisition Acquires Novaheal.
  4. Funding Latest funding round, Series C, of $259.1M.

Web traffic of AMBOSS

The website of AMBOSS (amboss.com) receives about 7.1M visits a month and ranks #5,926 among all websites worldwide, #82 in Medicine.

  • Monthly visits
    7.1M

    ▲ 16.5% vs previous month

  • Unique visitors
    901.8K

    per month

  • Global rank
    #5,926

    among all websites

  • Category rank
    #82

    Health · Medicine

Similar websites

Websites whose visitors overlap most with AMBOSS. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
osmosis.org
100%
2.4M#25,189View details
mynbme.org
mynbme.org
99%
#47,208–
nbme.org
99%
#81,019View details
starttest.com
starttest.com
98%
#51,596–
usmle.org
98%
#88,284View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for AMBOSS

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Amboss

Premium access

Complete news archive for AMBOSS

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about AMBOSS

AMBOSS was founded in 2012 and raised its 1st funding round 5 years after it was founded.

AMBOSS is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.

Madjid Salimi is the CEO of AMBOSS, as recorded in our data. They have also founded this company.

AMBOSS is a funded company, having raised a total of $291.94M across 3 funding rounds to date.

AMBOSS was founded in 2012 in Berlin, Germany, and operates in the medical education sector. Cloud-based and mobile resources, including question banks, review books, textbooks, lecture notes, personal notes, and multimedia, are provided for medical students and physicians. Learning cards are offered specifically for physicians on a subscription basis. The platforms app is available for Android and iOS devices.

AMBOSS offers AMBOSS Platform, Qbank, Knowledge Library, and AMBOSS App.

AMBOSS has made 1 acquisition, including Novaheal.

AMBOSS has 8 investors. Key investors include M&G, Partech Partners, Lightrock, KIRKBI, and Target Global.

AMBOSS operates through Amboss Gmbh.

Yes. AMBOSS publishes AMBOSS Knowledge Library and 1 more app, with over 500,000 downloads.

The website of AMBOSS receives about 7.1 million visits a month and ranks #5,926 among all websites worldwide.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available